Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Non-Small-Cell Lung 11Esophageal Squamous Cell Carcinoma 8Esophageal Neoplasms 7Uterine Cervical Neoplasms 6Squamous Cell Carcinoma of Head and Neck 6Nasopharyngeal Carcinoma 6Lung Neoplasms 6Head and Neck Neoplasms 5Gallbladder Neoplasms 5Cholangiocarcinoma 5Pancreatic Neoplasms 4Mesothelioma 4Breast Neoplasms 4Biliary Tract Neoplasms 4Stomach Neoplasms 3Oropharyngeal Neoplasms 3Neoplasm Metastasis 3Carcinoma 3Urinary Bladder Neoplasms 2Osteosarcoma 2Neoplasms 2Endometrial Neoplasms 2Carcinoma, Transitional Cell 2Carcinoma, Squamous Cell 2Bile Duct Neoplasms 2Adenocarcinoma Of Esophagus 2Triple Negative Breast Neoplasms 1Thymoma 1Thymic epithelial tumor 1Testicular Neoplasms 1

Interventions

pegylated granulocyte colony-stimulating factor 1pegfilgrastim 1merphos 1durvalumab 1Vinblastine 1Specimen Handling 1Platinum 1Methotrexate 1Magnetic Resonance Spectroscopy 1Immunoglobulin G 1Gemcitabine 1Doxorubicin 1Disulfides 1Cisplatin 1Biopsy 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2/3 × Renal Pelvis and Ureter Urothelial Carcinoma × Cisplatin × Clear all
NCT04628767 2026-06-03

Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer

National Cancer Institute (NCI)

Phase 2/3 Recruiting
131 enrolled
Genitourinary

Renal Pelvis and Ureter Urothelial Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡